Creon in HIV Patients With Steatorrhea

Steatorrhea Clinical Trial

Official title:
Double-blind, Cross-over, Randomized, Placebo-controlled, Multi-center Study to Investigate the Effect of Creon®25 000 on the Coefficient of Fat Absorption of HIV-infected Patients

Status Terminated

Clinical Trial Summary

The study investigates the effect of pancreatic enzymes on steatorrhea in HIV patients.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Steatorrhea

Clinical Trial Details

NCT number	NCT00623025
Study type	Interventional
Source	Abbott
Contact
Status	Terminated
Phase	Phase 3
Start date	January 2009
Completion date	August 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01184378` - Tolerance and Digestibility of a New Formula in Healthy Infants	Phase 2
Completed	`NCT00676702` - A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)	Phase 1
Completed	`NCT00217204` - An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption	Phase 2
Completed	`NCT00662675` - A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency	Phase 3